5-MeO-DMT

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
psychedelic tryptamine
gptkbp:CASNumber 1019-45-0
gptkbp:category alkaloid
Hallucinogen
serotonin receptor agonist
gptkbp:chemicalFormula C13H18N2O
gptkbp:color white to off-white
gptkbp:discoveredBy gptkb:Hoshino_and_Shimodaira
gptkbp:discoveredIn 1936
gptkbp:duration short (15–60 minutes)
gptkbp:effect psychedelic
hallucinogenic
entactogenic
gptkbp:excretion renal
gptkbp:hasInChIKey GMCMZNCUTQYNRU-UHFFFAOYSA-N
gptkbp:hasSMILES CN(C)CCc1c[nH]c2ccc(OC)cc12
https://www.w3.org/2000/01/rdf-schema#label 5-MeO-DMT
gptkbp:IUPACName gptkb:2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
gptkbp:legalStatus gptkb:Schedule_III_(Canada)
gptkb:Schedule_I_(United_States)
gptkb:Class_A_(United_Kingdom)
Schedule 9 (Australia)
gptkbp:mainStreet gptkb:Dragon
gptkb:The_God_Molecule
Five-MeO
gptkbp:mechanismOfAction 5-HT2A receptor agonist
serotonin receptor agonist
gptkbp:metabolism gptkb:monoamine_oxidase
gptkbp:molecularWeight 218.30 g/mol
gptkbp:occurredIn gptkb:toad_venom_(Incilius_alvarius)
various plant species
gptkbp:PubChem_CID 1976
CHEMBL2110612
gptkbp:relatedTo gptkb:DMT
gptkb:psilocin
gptkb:bufotenin
gptkbp:riskFactor risk of death in rare cases
risk of psychological distress
risk of serotonin syndrome
gptkbp:routeOfAdministration injection
oral
insufflation
vaporization
gptkbp:solubility slightly soluble in water
soluble in ethanol
soluble in chloroform
gptkbp:toxicity high in overdose
gptkbp:UNII YFQ03L43G8
gptkbp:usedIn shamanic rituals
entheogenic practices
gptkbp:bfsParent gptkb:DMT
gptkb:Anadenanthera_peregrina
gptkb:Anadenanthera_seeds
gptkbp:bfsLayer 7